Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
Background: Rituximab has been used successfully in the recent years for treatment of neuromyelitis optica spectrum disorders (NMOSD). However, a uniform treatment protocol for maintenance therapy and the best interval for evaluation and retreatment have not been postulated. We evaluated the efficac...
Main Authors: | Maral Seyed Ahadi, Abdorreza Naser Moghadasi, Nasrin Asgari, Mohammad Ali Sahraian |
---|---|
Format: | Article |
Language: | English |
Published: |
Babol University of Medical Sciences
2020-03-01
|
Series: | Caspian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://caspjim.com/article-1-1877-en.html |
Similar Items
-
Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder
by: Jie Lin, et al.
Published: (2022-05-01) -
Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
by: Maral Seyed Ahadi, et al.
Published: (2021-07-01) -
Pediatric Neuromyelitis Optica Spectrum Disorders: Three Case Reports and Review of Literature
by: Seyed Mohammad Baghbanian, et al.
Published: (2020-04-01) -
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
by: Fulin Gao, et al.
Published: (2019-03-01) -
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
by: Masoud Etemadifar, et al.
Published: (2017-01-01)